Hospira Stock Seesaws After Mixed Q4 Report, Guidance
Shares of Hospira (HSP) hit a six-month high early Wednesday, but then plunged and was down more than 8% in afternoon trading, after the company issued a mixed earnings report and continued its struggles with the FDA. The company, which sells a mixture of generic drugs and drug-delivery devices, narrowly beat analysts' Q4 expectations with profit of 55 cents a share and sales of $1.1 billion, both up 8% from the year-earlier quarter. However, its
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here